-
Something wrong with this record ?
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
K Kotseva, D Wood, Backer G De, Bacquer D De, K Pyorala, U Keil, Study Group EUROASPIRE
Language English Country Great Britain
Document type Comparative Study, Research Support, Non-U.S. Gov't
Grant support
NR9333
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
ProQuest Central
from 1992-01-04 to 3 months ago
Nursing & Allied Health Database (ProQuest)
from 1992-01-04 to 3 months ago
Health & Medicine (ProQuest)
from 1992-01-04 to 3 months ago
Family Health Database (ProQuest)
from 1992-01-04 to 3 months ago
Psychology Database (ProQuest)
from 1992-01-04 to 3 months ago
Health Management Database (ProQuest)
from 1992-01-04 to 3 months ago
Public Health Database (ProQuest)
from 1992-01-04 to 3 months ago
ScienceDirect (archiv)
from 1993-01-01 to 2009-12-31
- MeSH
- Exercise MeSH
- Diet MeSH
- Hypercholesterolemia * epidemiology drug therapy complications MeSH
- Cardiovascular Diseases * etiology prevention & control MeSH
- Smoking * epidemiology adverse effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Obesity * epidemiology complications MeSH
- Smoking Prevention MeSH
- Cross-Sectional Studies MeSH
- Risk Factors MeSH
- Aged MeSH
- Health Surveys MeSH
- Life Style * MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Geographicals
- Europe MeSH
BACKGROUND: The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular risk factors in patients with coronary heart disease. The third EUROASPIRE survey was done in 2006-07 in 22 countries to see whether preventive cardiology had improved and if the Joint European Societies' recommendations on cardiovascular disease prevention are being followed in clinical practice. METHODS: EUROASPIRE I, II, and III were designed as cross-sectional studies and included the same selected geographical areas and hospitals in the Czech Republic, Finland, France, Germany, Hungary, Italy, the Netherlands, and Slovenia. Consecutive patients (men and women =70 years) were identified after coronary artery bypass graft or percutaneous coronary intervention, or a hospital admission with acute myocardial infarction or ischaemia, and were interviewed at least 6 months later. FINDINGS: 3180 patients were interviewed in the first survey, 2975 in the second, and 2392 in the third. Overall, the proportion of patients who smoke has remained nearly the same (20.3% in EUROASPIRE I, 21.2% in II, and 18.2% in III; comparison of all surveys p=0.64), but the proportion of women smokers aged less than 50 years has increased. The frequency of obesity (body-mass index >/=30 kg/m(2)) increased from 25.0% in EUROASPIRE I, to 32.6% in II, and 38.0% in III (p=0.0006). The proportion of patients with raised blood pressure (>/=140/90 mm Hg in patients without diabetes or >/=130/80 mm Hg in patients with diabetes) was similar (58.1% in EUROASPIRE I, 58.3% in II, and 60.9% in III; p=0.49), whereas the proportion with raised total cholesterol (>/=4.5 mmol/L) decreased, from 94.5% in EUROASPIRE I to 76.7% in II, and 46.2% in III (p<0.0001). The frequency of self-reported diabetes mellitus increased, from 17.4%, to 20.1%, and 28.0% (p=0.004). INTERPRETATION: These time trends show a compelling need for more effective lifestyle management of patients with coronary heart disease. Despite a substantial increase in antihypertensive and lipid-lowering drugs, blood pressure management remained unchanged, and almost half of all patients remain above the recommended lipid targets. To salvage the acutely ischaemic myocardium without addressing the underlying causes of the disease is futile; we need to invest in prevention.
Charles University Medical Faculty Pilsen
Department of Preventive Cardiology Institute of Clinical Experimental Medicine Prague
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13011834
- 003
- CZ-PrNML
- 005
- 20200521103015.0
- 007
- ta
- 008
- 130402s2009 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S0140-6736(09)60330-5 $2 doi
- 035 __
- $a (PubMed)19286092
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kotseva, Kornelia $u Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK.
- 245 10
- $a Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries / $c K Kotseva, D Wood, Backer G De, Bacquer D De, K Pyorala, U Keil, Study Group EUROASPIRE
- 520 9_
- $a BACKGROUND: The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular risk factors in patients with coronary heart disease. The third EUROASPIRE survey was done in 2006-07 in 22 countries to see whether preventive cardiology had improved and if the Joint European Societies' recommendations on cardiovascular disease prevention are being followed in clinical practice. METHODS: EUROASPIRE I, II, and III were designed as cross-sectional studies and included the same selected geographical areas and hospitals in the Czech Republic, Finland, France, Germany, Hungary, Italy, the Netherlands, and Slovenia. Consecutive patients (men and women </=70 years) were identified after coronary artery bypass graft or percutaneous coronary intervention, or a hospital admission with acute myocardial infarction or ischaemia, and were interviewed at least 6 months later. FINDINGS: 3180 patients were interviewed in the first survey, 2975 in the second, and 2392 in the third. Overall, the proportion of patients who smoke has remained nearly the same (20.3% in EUROASPIRE I, 21.2% in II, and 18.2% in III; comparison of all surveys p=0.64), but the proportion of women smokers aged less than 50 years has increased. The frequency of obesity (body-mass index >/=30 kg/m(2)) increased from 25.0% in EUROASPIRE I, to 32.6% in II, and 38.0% in III (p=0.0006). The proportion of patients with raised blood pressure (>/=140/90 mm Hg in patients without diabetes or >/=130/80 mm Hg in patients with diabetes) was similar (58.1% in EUROASPIRE I, 58.3% in II, and 60.9% in III; p=0.49), whereas the proportion with raised total cholesterol (>/=4.5 mmol/L) decreased, from 94.5% in EUROASPIRE I to 76.7% in II, and 46.2% in III (p<0.0001). The frequency of self-reported diabetes mellitus increased, from 17.4%, to 20.1%, and 28.0% (p=0.004). INTERPRETATION: These time trends show a compelling need for more effective lifestyle management of patients with coronary heart disease. Despite a substantial increase in antihypertensive and lipid-lowering drugs, blood pressure management remained unchanged, and almost half of all patients remain above the recommended lipid targets. To salvage the acutely ischaemic myocardium without addressing the underlying causes of the disease is futile; we need to invest in prevention.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a senioři $7 D000368
- 650 12
- $a kardiovaskulární nemoci $x etiologie $x prevence a kontrola $7 D002318
- 650 02
- $a průřezové studie $7 D003430
- 650 02
- $a dieta $7 D004032
- 650 02
- $a cvičení $7 D015444
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a zdravotnické přehledy $7 D006306
- 650 02
- $a lidé $7 D006801
- 650 12
- $a hypercholesterolemie $x epidemiologie $x farmakoterapie $x komplikace $7 D006937
- 650 12
- $a životní styl $7 D008019
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 12
- $a obezita $x epidemiologie $x komplikace $7 D009765
- 650 02
- $a rizikové faktory $7 D012307
- 650 12
- $a kouření $x epidemiologie $x škodlivé účinky $7 D012907
- 650 _2
- $a prevence kouření $7 D000074606
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Wood, David
- 700 1_
- $a De Backer, Guy
- 700 1_
- $a De Bacquer, Dirk
- 700 1_
- $a Pyorala, Kalevi
- 700 1_
- $a Keil, Ulrich
- 700 1_
- $a Simon, J. $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Linhartová, Kateřina, $d 1964- $7 xx0063473 $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Haman, Petr $7 xx0086431 $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Mayer, Otto, $d 1969- $7 xx0053346 $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Rosolová, Hana, $d 1954- $7 jn20000402132 $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Boček, Pavel $7 xx0070533 $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Hrbková, Jana. $7 _BN005084 $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Patraulea, Monica. $7 xx0243767 $u Charles University, Medical Faculty, Pilsen
- 700 1_
- $a Hrnčárek, Marek, $d 1966- $7 xx0077273 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Lupínek, Petr, $d 1965- $7 xx0057868 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Marek, Tomáš $7 xx0059973 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Plasková, M. $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Škodová, Zdenka $7 xx0153069 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Cífková, Renata, $d 1955- $7 nlk20010094490 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Galovcová, Markéta, $d 1974- $7 xx0156655 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Bruthans, Jan, $d 1948- $7 jn20000810219 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 700 1_
- $a Bělohoubek, Jiří. $7 xx0194663 $u Department of Preventive Cardiology, Institute of Clinical Experimental Medicine, Prague
- 773 0_
- $t The lancet $g Roč. 373, č. 9667 (2009), s. 929-940 $p Lancet $x 0140-6736 $w MED00010161
- 773 0_
- $p Lancet $g 373(9667):929-40, 2009 Mar 14
- 910 __
- $a ABA008 $y 3 $z 0
- 990 __
- $a 20130402130027 $b ABA008
- 991 __
- $a 20200521103029 $b ABA008
- 999 __
- $a ok $b bmc $g 974791 $s 810111
- BAS __
- $a 3
- BMC __
- $x MED00010161 $i 0140-6736 $a 2009 $b 373 $c 9667 $d 929-940 $m Lancet $n Lancet
- GRA __
- $a NR9333 $p MZ0
- LZP __
- $a 2013-04/lmbo